What is the recommended work‑up and treatment for a patient with bilateral iliac artery aneurysms and tricuspid valve vegetations?

Management of Bilateral Iliac Artery Aneurysms with Tricuspid Valve Vegetations

These two conditions require simultaneous but distinct management strategies: immediate antimicrobial therapy for infective endocarditis with selective surgical intervention for the tricuspid vegetations, followed by staged endovascular repair of the iliac aneurysms once infection is controlled.

Initial Priority: Address the Infective Endocarditis

The tricuspid vegetations represent active infective endocarditis and take precedence due to mortality risk from septic emboli and bacteremia.

Immediate Actions:

• Obtain blood cultures (at least 3 sets from different sites before antibiotics)
• Start empiric broad-spectrum antibiotics immediately after cultures, covering Staphylococcus aureus (most common in right-sided IE) and consider antifungal coverage if risk factors present 1
• Perform transesophageal echocardiography to assess vegetation size, valve function, and degree of tricuspid regurgitation 1
• Assess for IV drug use history as this is the primary substrate for tricuspid IE 1

Medical Management of Tricuspid IE:

For methicillin-sensitive S. aureus (MSSA), 2-week treatment with oxacillin or cloxacillin without gentamicin is effective if ALL of the following criteria are met 1:

• MSSA organism confirmed
• Good clinical response to treatment
• No metastatic infection sites or empyema
• No evidence of left-sided involvement

Adjust antibiotics once organisms are isolated - do not continue empiric therapy blindly 1.

Surgical Indications for Tricuspid Vegetations:

Surgery should be considered (Class IIa, Level C) in these specific scenarios 1:

• Persistent bacteremia >7 days despite adequate antibiotics (especially S. aureus or Pseudomonas aeruginosa)
• Organisms difficult to eradicate (persistent fungi)
• Vegetations >20 mm with recurrent pulmonary emboli ± right heart failure
• Right heart failure from severe tricuspid regurgitation with poor diuretic response

Critical caveat: In IV drug users, surgery should generally be avoided due to high recurrence rates with continued drug abuse, unless the above criteria are met 1.

Secondary Priority: Bilateral Iliac Artery Aneurysms

Timing Strategy:

Defer iliac aneurysm repair until IE is controlled - typically after completing antibiotic course and documenting negative blood cultures. Operating on vascular aneurysms in the setting of active bacteremia risks graft infection.

Workup for Iliac Aneurysms:

• CT angiography with contrast to define:
  • Maximum aneurysm diameter (both sides)
  • Proximal and distal landing zones
  • Internal iliac artery (IIA) involvement bilaterally
  • Infrarenal aortic diameter
  • Common iliac artery neck diameter and length

Treatment Thresholds:

Elective repair is justified for asymptomatic iliac aneurysms ≥3.5 cm 2. This threshold is based on data showing no ruptures occurred below 3.8 cm, and mean expansion rate is 0.29 cm/year (faster with hypertension: 0.32 vs 0.14 cm/year) 2.

Endovascular vs Open Repair:

Endovascular repair (EVAR) should be first-line for anatomically suitable patients 2, 3, 4, 5:

• Zero 30-day mortality for elective EVAR vs 1% for open repair 2
• Lower complication rates and shorter hospitalization 2
• 100% stent-graft patency at mean 51-month follow-up 4
• Similar 3-year secondary patency (99.6% open vs 100% EVAR) 2

Technical Approach for Bilateral Iliac Aneurysms:

Primary goal: Exclude aneurysm sac while preserving at least one internal iliac artery to prevent pelvic ischemia 6.

For standard anatomy:

• Use iliac branch devices (IBD) when feasible to preserve IIA 6
• Alternative: "Bell-bottom" endograft at common iliac bifurcation 3
• May require coil occlusion of one hypogastric artery with extension into external iliac 3

For challenging anatomy (small infrarenal aorta <13 mm, no adequate landing zone):

• Consider aortic bifurcated unibody endograft with modified sandwich technique 6
• This approach showed no endoleaks or sac expansion at 2-year follow-up 6

Open Repair Indications:

Reserve open surgery for 5:

• Anatomically unsuitable for endovascular repair
• Symptoms from extrinsic compression of adjacent structures
• Failed endovascular repair

Critical Pitfalls to Avoid:

1. Do NOT operate on iliac aneurysms during active IE - risk of graft infection is prohibitive
2. Do NOT rush to tricuspid valve surgery in IV drug users unless meeting strict criteria - high recurrence rates 1
3. Do NOT sacrifice both internal iliac arteries if possible - risk of buttock claudication, erectile dysfunction, and pelvic ischemia
4. Do NOT delay IE treatment to address asymptomatic iliac aneurysms - infection takes priority
5. Watch for aortocaval fistula - rare but can masquerade as primary tricuspid disease; check for elevated IVC oxygen saturation if right heart failure seems disproportionate 7

Monitoring Strategy:

During IE treatment:

• Serial blood cultures until negative
• Weekly echocardiography to assess vegetation size and valve function
• Monitor for embolic complications (pulmonary emboli, septic pulmonary infarcts)

After iliac EVAR:

• CT scan at 1 month post-procedure
• Annual CT for first 2 years, then every 5 years if stable 8
• Monitor for endoleaks (reintervention rate ~19% at mean 51 months) 4